Header Logo

Connection

Sheilah Clayton to Trastuzumab

Back to Details
This is a "connection" page, showing publications Sheilah Clayton has written about Trastuzumab.
Sheilah Clayton
Connection Strength
0.034
Trastuzumab
  1. A83-01 inhibits TGF-ß-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun; 163(3):449-460.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.